Market Access, Pricing, Value and Evidence, Pharma Pricing 2018, 20 – 21 March 2018, pharma conference 2013.#Pharma #conference #2013


Posted On Jan 18 2018 by

Market Access, Pricing, Value and Evidence

Carla Deakin, Associate Director, Office for Market Access, NICE

Carla DeakinAssociate Director, Office for Market Access (OMA), National Institute for Health and Care Excellence.В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В Originally a biomedical scientist in the NHS, Carla spent 25 years in the UK Diagnostics industry, gaining both commercial and healthcare.

Sebastien Le Roux, VP, Global Market Access & Healthcare Solutions, Glaxo Smith Kline Inc

Sebastien Le Roux, currently VP, Global Market Access at GSK. Sebastien is a trained Pharmacist and has a Master Degree in Pharmaceutical industry from ESCP-EAP Business school in Paris.Sebastien has 20+ more years of experience in the pharmaceutical sector and held various commercial positions.

Alexander Natz, Secretary General, EUCOPE

Dr. Alexander Natz, LL.M. (Duke)Alexander Natz is the Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (www.eucope.org) in Brussels and works as a lawyer in the healthcare boutique law firm NOVACOS in DГјsseldorf (www.novacos-law.com). He advises innovative.

Tanya Potashnik, Director Policy & Economic Analysis, Patented Medicine Prices Review Board, Goverment Of Canada

A career public servant, Tanya Potashnik possesses a breadth of knowledge in the area of pharmaceutical policy, market dynamics and pricing in Canada and internationally.Prior to this role, Tanya served as manager and senior economist at the Board in charge of, among other things, the National.

Gundula Schneidewind, Vice President, Takeda

Gundula Schneidewind Medical Doctor, PhDTakeda Pharma International, Zurich, SwitzerlandGundula joined Takeda Germany in April 2013 as Head of Market Access. Since September 2015, she has been serving as VP Medical Affairs at TakedaВґs Regional Headquarter, overseeing Europe Canada (EUCAN). .

Rob Scott, Chief Medical Officer, VP, Head of Development, AbbVie

Dr Rob Scott is Zimbabwean born and studied medicine at the University of Cape Town. For thirty years Rob has held leadership positions in global Pharma, starting with J J in South Africa. As the Global Head of CV and Metabolic at Pfizer he was responsible for what was then the world’s largest.

John Bardi, Vice President Public Affairs and Digital Medicine Business Development, Otsuka America Pharmaceuticals Inc.

John Bardi is Vice President, Government Affairs, Digital Medicines Business Development at Otsuka America Pharmaceutical, Inc. (OAPI). John oversees strategic business development for Otsuka’s digital platform as well as the execution of government policy and advocacy.Before joining.

What is the

World Pharma Pricing & Market Access Congress

Bringing together international payers, industry professionals and patient associations, the 2-day meeting will address how to enhance your pricing and access strategy for the ever changing global healthcare market.

The 12th annualВ World Pharma Pricing & Market Access CongressВ is your opportunity to engage and sit alongside the pioneers who are driving forward effective access and pricing strategies. В

Pharma conference 2013


Last Updated on: January 17th, 2018 at 11:32 pm, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *